Prophylaxis for acute exacerbations of chronic bronchitis using an antibacterial sublingual vaccine obtained through mechanical lysis: A clinical and pharmacoeconomic study

Acta Biomedica de l'Ateneo Parmense

Volumn 74, Issue 2, 2003, Pages 81-87+108

  Cogo, Roberto ^a,c   Ramponi, Alessandro ^a   Scivoletto, Giorgio ^d   Rippoli, Rosa ^b  

^a Ospedale A Zappatoni   (Italy)

^b Opera Pia Porro di Barlassina   (Italy)

^c UO di Riabilitazione Respiratoria   (Italy)

^d NONE

Author keywords

Chronic obstructive bronchitis (COB); COB exacerbations; Polyvalent mechanical bacterial lysate (PMBL); Prophylactic vaccine

Indexed keywords

BACTERIAL VACCINE; BACTERIUM LYSATE; ISMIGEN; POLYVALENT MECHANICAL BACTERIAL LYSATE; UNCLASSIFIED DRUG;

ACUTE DISEASE; AGED; ARTICLE; BACTERIAL INFECTION; CHRONIC BRONCHITIS; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG COST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME; VACCINATION;

ACUTE DISEASE; ADMINISTRATION, SUBLINGUAL; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL VACCINES; BACTERIOLYSIS; BRONCHITIS, CHRONIC; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY, ACTIVE; MALE; SEASONS; TIME FACTORS;

EID: 0042416538     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Blasi F, Vaccinoprofilassi delle infezioni respiratorie: efficacia di un lisatto batterico per via meccanica. Giorn It Mal Tor 2002; 56: 85-99.
2. Raccomandazioni del Consiglio delle Comunità Europee, sull'uso prudente degli agenti antimicrobici nella medicina umana. Gazzetta Ufficiale delle Comunità Europee, 5 2 2002; L34:13-6.
3. Melioli G. Opsonizzazione: mangiare o essere mangiato. Giorn It Mal Tor 2002; 56: 245-8.
4. Collet JP, Ducruet T, Haider S, Shapiro S, Robinson A, Renzi PM, Contandriopoulos AP, Ernst P. Economic impact of using immunostimulating agent to prevent severe acute exacerbations in patients with chronic obstructive pulmonary disease. Can Respir J 2001; 8: 27-33.
5. Rossi S, Tazza R. Valutazione dell'efficacia e della tollerabilità di un nuovo vaccino immunostimolante (Ismigen®), ottenuto per lisi meccanica, nella prevenzione delle patologie infettive delle basse vie respiratorie. American College of Chest Physicians, Italian Chapter 2002.
6. Lydyard P, Grossi C. cells involved in the immune response. In: Immunology. Roit I, Brostoff J, Male D Eds. NY USA: Gowen Medical Publishing, 1990.
7. König W. Role of the immune system in the recovery from infection: Respiration 1993; 60: 16-24.
8. Clot J. Immunité anti-infectieuse. Mécanismes, facteurs, spécifiques et non spécifiques. Rev Prat (Paris) 1994; 44: 2505-12.
9. Bresdreska A. Local immunization. Baltimore: Williams and Wilkins; 1927.
10. Tomasi T.B, Bienenstock J. Secretory immunoglobulins. Adv Immunol 1968; 9: 1-96.
11. National Center for Health Statistics. Current estimates from the National Health Inteview Survey, United States, 1981. Vital and Health Statistic series, 10 (141). Washington: US Government Printing Office, 1982.
12. Bundesamt für Statistik. Statistischens Jahrbuch der Schweiz, 1993.
13. Workshop report "Global Initiative for the Diagnosis, Management and Prevention of chronic Obstuctive Lung Disease (GOLD)" - NHLBI, OMS. Am J Respir Crit Care Med 2001; 163: 1256-75.
14. Casone A. Vaccini e vaccinazioni antinfettive. Istituto Superiore della Sanità; Accademia Nazionale di Medicina, 2002.